Ramaswamy Gomathi, Yadav Kapil, Goel Akhil Dhanesh, Yadav Vikas, Arora Srishti, Vohra Kashish, Khanam Areeba, Kant Shashi
Department of Community Medicine and Family Medicine, All India Institute of Medical Sciences, Bibinagar, Telangana, India.
Centre for Community Medicine, Principal Investigator, National Centre of Excellence and Advanced Research on Anemia Control, All India Institute of Medical Sciences, New Delhi, India.
J Family Med Prim Care. 2022 Dec;11(12):7527-7536. doi: 10.4103/jfmpc.jfmpc_409_22. Epub 2023 Jan 17.
Fortification of staple food items with iron is a potential strategy to address anemia for a larger population. We reviewed studies to assess the impact of iron-fortified rice (IFR) on hemoglobin levels of individuals more than six months of age. We included studies assessing the effectiveness of IFR (with or without other micronutrients) conducted in any part of the world available in PubMed, Embase, Web of Science, Cochrane Library, Google Scholar, clinicaltrials.gov, International database of prospectively registered systematic reviews in health and social care (PROSPERO), unicef.org, and who.int databases and published from January 1, 1990 to April 1, 2019 (PROSPERO registration number: RD42020139895). We extracted the changes in hemoglobin, serum ferritin, and serum transferrin levels among the participants. Finally, data from 15 trials and their 21 subsets were analyzed. Mean difference in hemoglobin was 0.53 g/dl (95% CI: 0.26, 0.80, P < 0.001, I2 = 84%) in the IFR group compared to the control group. In the subgroup analysis after removing studies with small sample size and high risk for bias, a mean difference of 0.44 g/dl (95% CI: 0.20, 0.69, P < 0.001, I2 = 82%) was observed. No significant effect on serum ferritin or transferrin levels was observed. From this review it can be concluded that fortification of rice with iron can be adopted as an intervention to improve hemoglobin levels, especially in countries where rice is the major part food of staple diet. Research is needed on an optimal iron compound for fortification and the acceptance of IFR.
对主食进行铁强化是解决更多人群贫血问题的一项潜在策略。我们回顾了相关研究,以评估铁强化大米(IFR)对6个月以上个体血红蛋白水平的影响。我们纳入了在PubMed、Embase、科学网、Cochrane图书馆、谷歌学术、clinicaltrials.gov、健康与社会护理前瞻性注册系统评价国际数据库(PROSPERO)、联合国儿童基金会网站和世界卫生组织网站数据库中可获取的、于1990年1月1日至2019年4月1日期间在世界任何地区开展的评估IFR(含或不含其他微量营养素)有效性的研究(PROSPERO注册号:RD42020139895)。我们提取了参与者血红蛋白、血清铁蛋白和血清转铁蛋白水平的变化情况。最后,对15项试验及其21个子集的数据进行了分析。与对照组相比,IFR组的血红蛋白平均差异为0.53 g/dl(95%置信区间:0.26,0.80,P<0.001,I² = 84%)。在剔除样本量小且偏倚风险高的研究后的亚组分析中,观察到平均差异为0.44 g/dl(95%置信区间:0.20,0.69,P<0.001,I² = 82%)。未观察到对血清铁蛋白或转铁蛋白水平有显著影响。从该综述可以得出结论,铁强化大米可作为一种干预措施来提高血红蛋白水平,尤其是在大米是主食主要组成部分的国家。需要对用于强化的最佳铁化合物以及IFR的可接受性进行研究。